A Randomized Open-Labeled Trial of Methotrexate as a Steroid-Sparing Agent for Patients With Generalized Myasthenia Gravis

Comparison of Corticosteroid Tapering Regimens in Myasthenia Gravis

(2021) Tarek Sharshar et al.   JAMA Neurology

Overview of Dual-Acting Drug Methotrexate in Different Neurological Diseases, Autoimmune Pathologies and Cancers

(2020) Przemysław Koźmiński et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Myasthenia gravis

(2019) Nils Erik Gilhus et al.   Nature Reviews Disease Primers

Optimising Low Dose Methotrexate for Rheumatoid Arthritis – A Review

(2019) Catherine J. Lucas et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Treatment of Myasthenia Gravis

(2018) Constantine Farmakidis et al.   NEUROLOGIC CLINICS

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

(2017) James F Howard et al.   LANCET NEUROLOGY

Letter re: A randomized controlled trial of methotrexate for patients with generalized myasthenia gravis

(2017) Jeannine M. Heckmann et al.   NEUROLOGY

Author response: A randomized controlled trial of methotrexate for patients with generalized myasthenia gravis

(2017) Mamatha Pasnoor   NEUROLOGY

Letter re: A randomized controlled trial of methotrexate for patients with generalized myasthenia gravis

(2017) Praful Kelkar   NEUROLOGY

Meta-Regression of a Dose-Response Relationship of Methotrexate in Mono- and Combination Therapy in Disease-Modifying Antirheumatic Drug-Naive Early Rheumatoid Arthritis Patients

(2017) S. A. Bergstra et al.   ARTHRITIS CARE & RESEARCH

Tacrolimus in the treatment of myasthenia gravis in patients with an inadequate response to glucocorticoid therapy: randomized, double-blind, placebo-controlled study conducted in China

(2017) Lei Zhou et al.   Therapeutic Advances in Neurological Disorders

Comment: Methotrexate for patients with generalized myasthenia gravis

(2016) Daniel B. Drachman   NEUROLOGY

A randomized controlled trial of methotrexate for patients with generalized myasthenia gravis

(2016) Mamatha Pasnoor et al.   NEUROLOGY

Determining the Lowest Optimally Effective Methotrexate Dose for Individual RA Patients Using Their Dose Response Relation in a Tight Control Treatment Approach

(2016) Sandhya C. Nair et al.   PLoS One

The effects of prednisone and steroid-sparing agents on decay accelerating factor (CD55) expression: Implications in myasthenia gravis

(2014) Jennifer Auret et al.   NEUROMUSCULAR DISORDERS

Phase II trial of methotrexate in myasthenia gravis

(2012) Mamatha Pasnoor et al.   Annals of the New York Academy of Sciences

A single-blinded trial of methotrexate versus azathioprine as steroid-sparing agents in generalized myasthenia gravis

(2011) Jeannine M Heckmann et al.   BMC Neurology

Randomised, double-blind, placebo-controlled study of tacrolimus in myasthenia gravis

(2011) H. Yoshikawa et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Methotrexate—how does it really work?

(2010) Edwin S. L. Chan et al.   Nature Reviews Rheumatology

An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis

(2008) D. B. Sanders et al.   NEUROLOGY

Steroids and immunosuppressant drugs in myasthenia gravis

(2008) Sivakumar Sathasivam   Nature clinical practice. Neurology